NEW DELHI – U.S. drugmaker Amgen plans to invest approximately $200 million this year in its new technology center located in ...
Johnson & Johnson (NYSE:JNJ) is suing Samsung Bioepis for breach of contract related to the launch of a biosimilar of J&J's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback